PMA device
Bulkamid Urethral Bulking System
Boston Scientific Corporation · Agent, Bulking, Injectable For Gastro-Urology Use (LNM, Class III) · First FDA decision Jan 28, 2020, newest Jan 28, 2020Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
8
Naming "Bulkamid Urethral"
MAUDE reports
45
Brand "Bulkamid Urethral", since 2015
PubMed studies
0
Mentioning "Bulkamid Urethral"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Bulkamid Urethral Bulking System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P170023 · Decided Jan 28, 2020 · 911 days after receipt
Device type: AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE (LNM) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Bulkamid Urethral", any status and sponsor, newest update first.
- Trial of NASHA Dx Urethral Bulking SystemPivotal-lookingNot yet recruiting
Palette Life Sciences, Inc.Not on our public-company list
NCT07850804 · 314 participants (planned) · Start Sep 2026 · Primary completion Sep 2027
Device: NASHA Dx; Bulkamid · For: Urinary Incontinence; Urinary Incontinence (UI); Urinary Incontinence , Stress and 4 more
Sites: Tustin, California; Lincoln, Nebraska; Charlotte, North Carolina · 5 sites in all
- Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary IncontinencePivotal-lookingRecruiting
NICHD Pelvic Floor Disorders NetworkResearch network
NCT06480227 · 358 participants (planned) · Start Aug 28, 2024 · Primary completion Dec 31, 2028
Device: Solyx Single-incision Sling; Bulkamid Transurethral Bulking Agent · For: Stress Urinary Incontinence; Urinary Incontinence; Mixed Urinary Incontinence
Sites: La Jolla, California; San Diego, California; Chicago, Illinois · 7 sites in all
- BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)Pivotal-lookingRecruiting
University Hospitals Cleveland Medical CenterAcademic, hospital or other
NCT06754046 · 476 participants (planned) · Start May 1, 2025 · Primary completion Apr 2029
Device: RP-MUS · For: Stress Urinary Incontinence; Vaginal Prolapse
Sites: Cleveland, Ohio
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Bulkamid Urethral", and for the whole product code for context.
This brand
45 reports: 1 malfunction, 43 injury, 1 death
Whole product code LNM
544 reports: 170 malfunction, 369 injury, 2 death
Newest reports for this brand
3002968685-2025-00175 · Received Oct 31, 2025 · Event dated Jan 24, 2022
Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abdominal Pain; Urinary Retention
3002968685-2025-00197 · Received Oct 31, 2025 · Event dated Aug 1, 2022
Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Incontinence; Urinary Retention
3002968685-2025-00216 · Received Oct 31, 2025 · Event dated Oct 13, 2022
Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection; Dysuria
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Axonics Modulation Technologies, Inc.
Z-2077-2021 · Started Jun 3, 2021
Reason given: Lack of Sterility Assurance; needle in procedure pack labeled as sterile may not have been adequately sterilized
Cause as FDA categorized it: Material/Component Contamination · Device type: Agent, Bulking, Injectable For Gastro-Urology Use (LNM)
Published research
The most relevant PubMed records for "Bulkamid Urethral"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LNM.
- Deflux Injectable GelPalette Life Sciences · PMA 2016
- Macroplastique ImplantsUroplasty, LLC · PMA 2023
- Solesta (Injectable Gel)Palette Life Sciences · PMA 2021
- Durasphere Injectable Bulking AgentCarbon Medical Technologies, Inc. · PMA 2026
- Coaptite Injectable ImplantMerz North America, Inc. · PMA 2024
- Contigen Bard Collagen ImplantAllergan, Inc. · PMA 2009
- Bard Tegress Urethral ImplantC.R. Bard, Inc. · PMA 2006
- Enteryx Procedure KitBoston Scientific Corp · PMA 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.